Birdwatch Note
2023-11-09 13:36:45 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
日本医療研究開発機構（AMED）の研究班による日本の一都市における新型コロナワクチン（mRNA型）接種後の一定期間とそれ以外の期間の死亡リスクを比較解析した結果では、新型コロナワクチン（mRNA型）接種後の死亡リスクについて、有意な上昇は認められなかったとされています https://www.cov19-vaccine.mhlw.go.jp/qa/0081.html またイベルメクチンが多くの人間を救っているとの記載がありますが、北里大学の研究によると新型コロナウイルスにはイベルメクチンは効果を発揮しないと結論付けられています。 https://www.asahi.com/articles/ASR787GV5R78TIPE01H.html 期限切れの薬品を使用する行為は、薬品が分解され成分が変質し、体に対して害を及ぼす場合があり大変危険です。 https://www.kusurinomadoguchi.com/column/kigenn-5789/#%E3%81%9D%E3%81%AE%E8%96%AC%E3%81%AF%E5%AE%89%E5%BF%83%EF%BC%9F%E8%96%AC%E3%81%AE%E4%BD%BF%E7%94%A8%E6%9C%9F%E9%99%90%E3%81%AB%E3%81%A4%E3%81%84%E3%81%A6
Written by DE046CA89824342596338C9BEE862F6A98B9155DFA6310F6F25D3E5F02188A96
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1722505339239829854
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1722609171068248571
- noteId - 1722609171068248571
- participantId -
- noteAuthorParticipantId - DE046CA89824342596338C9BEE862F6A98B9155DFA6310F6F25D3E5F02188A96 Participant Details
- createdAtMillis - 1699537005571
- tweetId - 1722505339239829854
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 日本医療研究開発機構（AMED）の研究班による日本の一都市における新型コロナワクチン（mRNA型）接種後の一定期間とそれ以外の期間の死亡リスクを比較解析した結果では、新型コロナワクチン（mRNA型）接種後の死亡リスクについて、有意な上昇は認められなかったとされています https://www.cov19-vaccine.mhlw.go.jp/qa/0081.html またイベルメクチンが多くの人間を救っているとの記載がありますが、北里大学の研究によると新型コロナウイルスにはイベルメクチンは効果を発揮しないと結論付けられています。 https://www.asahi.com/articles/ASR787GV5R78TIPE01H.html 期限切れの薬品を使用する行為は、薬品が分解され成分が変質し、体に対して害を及ぼす場合があり大変危険です。 https://www.kusurinomadoguchi.com/column/kigenn-5789/#%E3%81%9D%E3%81%AE%E8%96%AC%E3%81%AF%E5%AE%89%E5%BF%83%EF%BC%9F%E8%96%AC%E3%81%AE%E4%BD%BF%E7%94%A8%E6%9C%9F%E9%99%90%E3%81%AB%E3%81%A4%E3%81%84%E3%81%A6
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-11-09 13:36:45 UTC (1699537005571) |
2023-11-09 17:47:36 UTC (1699552056815) |
CURRENTLY_RATED_HELPFUL | 2023-11-10 02:56:01 UTC (1699584961849) |
CURRENTLY_RATED_HELPFUL | 2023-11-09 17:47:36 UTC (1699552056815) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2023-11-09 18:01:50 -0600 | Rating Details | |
| 2023-11-09 17:41:30 -0600 | Rating Details | |
| 2023-11-09 16:40:24 -0600 | Rating Details | |
| 2023-11-09 15:33:59 -0600 | Rating Details | |
| 2023-11-09 15:21:01 -0600 | Rating Details | |
| 2023-11-09 14:35:17 -0600 | Rating Details | |
| 2023-11-09 12:58:46 -0600 | Rating Details | |
| 2023-11-09 12:51:46 -0600 | Rating Details | |
| 2023-11-09 11:18:52 -0600 | Rating Details | |
| 2023-11-09 11:16:45 -0600 | Rating Details | |
| 2023-11-09 10:43:08 -0600 | Rating Details | |
| 2023-11-09 10:00:51 -0600 | Rating Details | |
| 2023-11-09 09:57:44 -0600 | Rating Details | |
| 2023-11-09 09:20:43 -0600 | Rating Details | |
| 2023-11-09 09:16:48 -0600 | Rating Details | |
| 2023-11-09 09:12:21 -0600 | Rating Details | |
| 2023-11-09 09:08:37 -0600 | Rating Details | |
| 2023-11-09 09:07:24 -0600 | Rating Details | |
| 2023-11-09 08:58:40 -0600 | Rating Details | |
| 2023-11-09 08:55:28 -0600 | Rating Details | |
| 2023-11-09 08:54:05 -0600 | Rating Details | |
| 2023-11-09 08:51:18 -0600 | Rating Details | |
| 2023-11-09 08:45:54 -0600 | Rating Details | |
| 2023-11-09 08:45:42 -0600 | Rating Details | |
| 2023-11-09 08:45:10 -0600 | Rating Details | |
| 2023-11-09 08:29:28 -0600 | Rating Details | |
| 2023-11-09 08:24:46 -0600 | Rating Details | |
| 2023-11-09 08:04:07 -0600 | Rating Details | |
| 2023-11-09 08:03:43 -0600 | Rating Details | |
| 2023-11-09 07:58:09 -0600 | Rating Details | |
| 2023-11-09 07:55:25 -0600 | Rating Details | |
| 2023-11-09 07:51:30 -0600 | Rating Details | |
| 2023-11-09 07:43:56 -0600 | Rating Details | |
| 2023-11-09 07:42:06 -0600 | Rating Details | |
| 2023-11-10 16:53:16 -0600 | Rating Details | |
| 2023-11-10 14:06:34 -0600 | Rating Details | |
| 2023-11-10 12:12:40 -0600 | Rating Details | |
| 2023-11-10 09:14:21 -0600 | Rating Details | |
| 2023-11-10 08:25:28 -0600 | Rating Details | |
| 2023-11-10 07:56:44 -0600 | Rating Details | |
| 2023-11-10 07:27:20 -0600 | Rating Details | |
| 2023-11-10 07:00:46 -0600 | Rating Details | |
| 2023-11-10 06:54:42 -0600 | Rating Details | |
| 2023-11-10 06:53:05 -0600 | Rating Details | |
| 2023-11-10 06:51:01 -0600 | Rating Details | |
| 2023-11-10 06:47:54 -0600 | Rating Details | |
| 2023-11-10 06:33:10 -0600 | Rating Details | |
| 2023-11-10 06:26:25 -0600 | Rating Details | |
| 2023-11-10 06:24:15 -0600 | Rating Details | |
| 2023-11-10 02:46:08 -0600 | Rating Details | |
| 2023-11-09 22:02:39 -0600 | Rating Details | |
| 2023-11-09 20:46:35 -0600 | Rating Details | |
| 2023-11-09 20:04:11 -0600 | Rating Details | |
| 2023-11-09 19:14:20 -0600 | Rating Details | |
| 2023-11-10 19:41:20 -0600 | Rating Details | |
| 2023-11-10 19:32:44 -0600 | Rating Details | |
| 2023-11-19 02:07:36 -0600 | Rating Details | |
| 2023-11-10 06:55:50 -0600 | Rating Details |